Processa Pharmaceuticals’ (PCSA) CEO David Young on Q2 2021 Results – Earnings Call Transcript
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Q2 2021 Earnings Conference Call August 12, 2021 5:30 PM ET
Company Participants
James Stanker – Chief Financial Officer
David Young – Chief Executive Officer
Conference Call Participants
François Brisebois -…
